Healthcare Services

Drug discovery services market insights highlighting growth opportunities through 2030

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Drug Discovery Services Market Expected To Change From 2026 To 2030?

The drug discovery services market size has witnessed rapid growth in recent years. It is projected to expand from $20.52 billion in 2025 to $23.21 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.1%. The market’s growth during the historic period can be ascribed to several factors including pharmaceutical R&D expansion, cost pressures faced by drug developers, the proliferation of CRO services, advancements in target-based drug discovery, and enhanced academic-industry collaborations.

The drug discovery services market size is projected to experience significant expansion in the coming years, reaching $39.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.4%. This anticipated growth can be credited to developments such as precision medicine pipelines, advanced AI-driven discovery platforms, increased funding for biotech startups, extensive research into complex diseases, and the necessity for faster lead optimization. Notable trends expected during this forecast period encompass the increasing outsourcing of drug discovery processes, the expanding application of AI in identifying targets, the broader availability of early-stage discovery services, a rising demand for biologics drug discovery, and the integrated use of in vitro and in vivo studies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Which Drivers Are Supporting The Drug Discovery Services Market Growth?

The increasing occurrence of chronic illnesses is anticipated to fuel expansion in the drug discovery services market in the future. These conditions are defined as persistent health issues that are typically manageable rather than curable. In this context, drug discovery services are crucial for identifying and advancing novel treatments aimed at chronic diseases. For example, data from September 2023 by the World Health Organization, a public health agency based in Switzerland, indicated that chronic noncommunicable diseases caused 41 million fatalities each year, accounting for 74% of total global deaths. Consequently, the growing incidence of chronic diseases is set to contribute to the overall expansion of the drug discovery services market.

How Is The Drug Discovery Services Market Segmented Across Different Segment Categories?

The drug discovery services market covered in this report is segmented –

1) By Type: Chemistry Services, Biology Services

2) By Process: Target Selection, Target Validation, Hit-To-Lead identification, Lead Optimization, Candidate Validation

3) By Drug Type: Biologics Drug , Small Molecule Drug

4) By End user: Pharmaceutical And Biotechnology Companies, Academic Institutes, Other End Users

Subsegments:

1) By Chemistry Services: Medicinal Chemistry, Compound Management, High-Throughput Screening, Lead Optimization

2) By Biology Services: In Vitro Studies, In Vivo Studies, Pharmacokinetics And Pharmacodynamics (PK Or PD), Biomarker Discovery

Which Trends Are Expected To Impact The Drug Discovery Services Market?

Leading companies in the drug discovery services market are innovating with advanced technologies, such as artificial intelligence (AI) and machine learning (ML), to boost the efficiency and accuracy of the drug discovery process. Artificial Intelligence (AI) and Machine Learning (ML) are closely linked fields within computer science; AI involves developing computer systems that can perform tasks typically requiring human intelligence, while ML, a subset of AI, focuses on using algorithms and statistical models to enable computers to learn from data and make predictions or decisions. For instance, in February 2024, Eurofins Discovery, a France-based company providing support services across various sectors, including pharmaceuticals, unveiled its innovative platform, DiscoveryAI SAFIRE (Suite of ADMET Predictions for In Silico Refinement and Evaluation). This advanced platform uses proprietary datasets, artificial intelligence (AI), and machine learning (ML) to enhance drug discovery. SAFIRE is designed to expedite the discovery of new pharmaceuticals by predicting the ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties of molecules. The platform utilizes data from Eurofins Discovery’s extensive BioPrint database, which has been meticulously curated over years of research.

Which Organizations Play A Role In The Drug Discovery Services Market Landscape?

Major companies operating in the drug discovery services market are Thermo Fisher Scientific Inc., Albany Molecular Research Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, Domainex Ltd., GenScript Biotech Corporation, Pharmaceutical Product Development LLC, Advinus Therapeutics Pvt. Ltd., Jubilant Biosys Ltd., Evotec AG, Syngene International Ltd., Bayer AG, Merck KGaA, Ubiquigent Ltd., Eurofins Scientific SE, AppTec Laboratory Services Inc., GVK Biosciences Private Limited, Aurigene Discovery Technologies Limited, Viva Biotech Holdings, Pharmaron Beijing Co. Ltd., Selcia Limited, Concept Life Sciences Group Limited, BioDuro LLC, ChemPartner Corporation, Aptuit LLC, Sygnature Discovery Limited, Peak Proteins Ltd., SRI International, BioAscent Discovery Limited, Sai Life Sciences Limited, Promega Corporation, MedChemExpress LLC, Aragen Bioscience Inc., WuXi STA, BioNTech SE, Moderna Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Amgen Inc., Bristol-Myers Squibb Company

Get The Full Drug Discovery Services Market Report:

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Which Region Represents The Largest Share Of The Drug Discovery Services Market?

North America was the largest region in the drug discovery services market in 2025. The regions covered in the drug discovery services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Drug Discovery Services Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Browse Through More Reports Similar to the Global Drug Discovery Services Market 2026, By The Business Research Company

Drug Discovery Informatics Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-informatics-global-market-report

Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Drug Discovery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795